Related Experiment Video
Updated: Jun 27, 2026

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
Published on: January 9, 2026
Microthrombotic/microangiopathic manifestations of the antiphospholipid syndrome
Sonja Praprotnik1, Dusan Ferluga, Alenka Vizjak
1Clinical Department of Rheumatology, University Medical Center Ljubljana, Ljubljana, Slovenia.
Abstract:
The paper presents an overview of clinical manifestations and histopathologic findings in different organs in microvascular thrombotic and microangiopathic antiphospholipid syndrome (MAPS). Subsets of antiphospholipid syndrome (APS) are presented and defined. Clinico-pathologic correlations seem insufficient so far, because of a lack of detailed systematic studies of the histopathology in different organs. Based on their own autopsy and biopsy studies, the authors propose a novel categorization of histopathologic lesions that occur in patients with classic and catastrophic APS. In addition to the already accepted category of a microvascular thrombotic type of lesions, microangiopathic lesions consistent with thrombotic microangiopathy are proposed to be included in new revised classification criteria for definite APS. Microvascular thrombotic and so far underestimated microangiopathic histopathologic lesions have been shown to appear in various combinations and of different ages in patients with both classic and catastrophic APS, which fits into the concept of MAPS. These preliminary findings of our studies are also in line with the most recent hypothesis of two main mechanisms in the pathogenesis of APS, emphasizing a key role of endothelial cell affection induced by aPL on the one hand and interference with coagulation cascade on the other side.
Insights
This study reclassifies antiphospholipid syndrome (APS) histopathology, proposing new criteria for definite APS. It highlights microvascular thrombotic and microangiopathic lesions in APS, crucial for understanding microangiopathic antiphospholipid syndrome (MAPS).
Area of Science:
- Pathology
- Rheumatology
- Hematology
Background:
- Antiphospholipid syndrome (APS) classification lacks detailed histopathologic correlation.
- Microvascular thrombotic and microangiopathic lesions are key in APS but require systematic study.
Purpose of the Study:
- To propose a novel categorization of histopathologic lesions in APS.
- To revise classification criteria for definite APS by including microangiopathic lesions.
- To explore clinico-pathologic correlations in microangiopathic antiphospholipid syndrome (MAPS).
Main Methods:
- Review of autopsy and biopsy studies in patients with APS.
- Analysis of histopathologic findings in various organs.
- Comparison of lesion types and ages in classic and catastrophic APS.
Main Results:
- A novel categorization of histopathologic lesions in APS is proposed.
- Inclusion of microangiopathic lesions in revised APS classification criteria is suggested.
- Microvascular thrombotic and microangiopathic lesions coexist and vary in age in APS patients, supporting the MAPS concept.
Conclusions:
- Histopathologic findings support the concept of microangiopathic antiphospholipid syndrome (MAPS).
- Revised classification criteria for APS should incorporate microangiopathic lesions.
- Endothelial cell affection and coagulation cascade interference are key pathogenic mechanisms in APS.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Endocarditis II: Clinical Features of Infective Endocarditis
Peripheral Artery Disease I: Introduction
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

